ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
MSD at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
MSD takes part in 6 sessions at ESMO 2026 in Madrid, and exhibits at Booth 8030. Its sessions focus on treatment decisions and practical care across several cancers. They cover ovarian and endometrial cancer, kidney and bladder cancer, and nursing considerations for immunotherapy given under the skin.
| Organization | ESMO 2026 Attendance |
|---|---|
Global pharmaceutical company, known as Merck & Co. in the US and Canada, whose oncology medicines include pembrolizumab. | Booth Exhibiting at Booth 8030 Satellite Fri Oct 23 09:45–11:15 MSD - Emerging Evidence and Treatment Integration in Ovarian and Endometrial Cancer Gynaecological cancersBiomarkers & precision oncology Satellite Sat Oct 24 12:00–13:30 Satellite Sat Oct 24 13:00–14:30 MSD - Practical MDT Considerations for the new Treatment Paradigm in Resectable LA HNSCC Sarcoma, CNS, head & neck and rare cancers Satellite Sun Oct 25 18:30–20:00 MSD - Is the precision medicine ecosystem ready? Overcoming diagnostic barriers in oncology Biomarkers & precision oncology Satellite Mon Oct 26 13:00–14:30 Daiichi Sankyo and MSD - Shaping the Future of ES-SCLC: Pioneering Treatment Strategies Lung & thoracic cancers Satellite Mon Oct 26 13:00–14:30 |
Find decision makers at MSD
Tell us what you sell and we’ll find the people at MSD most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction